WVS | ANYX: Latest Product is Based on Atomization Technology G-mesh

World Vape Show by 2FIRSTS
Jun.14.2024
WVS | ANYX: Latest Product is Based on Atomization Technology G-mesh
World Vape Show in Dubai featured ANYX brand leader Sanking discussing market performance, new products, and future plans.

The World Vape Show was held at the Dubai World Trade Center from June 12th to 14th. During the event, 2FIRSTS had a conversation with Sanking, the head of Anyx, a brand under the Yijiate Group, where he discussed the market performance of Anyx, new products, and future development plans.

WVS | ANYX: Latest Product is Based on Atomization Technology G-mesh
ANYX booth | Image source: 2FIRSTS

 

According to Sanking, the ANYX brand specializes in pod systems, including both open and closed systems, and also has entered the disposable e-cigarette market. The brand is continuously innovating its technology and has recently launched four new products, including Anyx-pro, Anyx-go, Anyx-polo, and Anyx-max.

WVS | ANYX: Latest Product is Based on Atomization Technology G-mesh
ANYX booth | Image source: 2FIRSTS

 

Sanking stated that ANYX primarily focuses its market in Europe, particularly in Italy and Spain, as well as in South America, the Middle East, and Southeast Asia, with the best performance seen in the Italian market. The brand name "ANYX" combines "any + possible," symbolizing endless possibilities and emphasizing user needs and perception.

 

This is ANYX's first participation in the world e-cigarette exhibition in Dubai. The Middle East market is a completely new territory for ANYX, as the brand only started expanding into this market at the end of 2022. Sanking stated that despite being a relatively new brand, the Middle East market will be a strategic focus for future extensive deployment.

 

At this exhibition, ANYX showcased its latest atomization core technology G-mesh and the products using it. While ANYX introduced a large-screen e-cigarette based on cartridge replacement, it remains cautious towards disposable large-screen e-cigarettes due to concerns about resource waste and environmental issues.

 

Sanking stated that the Middle East market has tremendous potential, and ANYX is currently in discussions with multiple local distributors for collaboration. The brand's plan is to combine online and offline experiences and user operations to increase market share. In the future, ANYX will launch products that better cater to the preferences of local consumers based on market demand, and will collaborate deeply with local partners.

 

Sanking stated that ANYX will focus on the European market and continue to explore opportunities in other emerging markets in the future. The brand will introduce products tailored to consumer demands based on market conditions, aiming to enhance user experience through technological innovation.

 

Finally, Sanking gave high praise to the e-cigarette exhibition in Dubai, considering it the largest in the world with significant influence. The large number of exhibitors, distributors, and visitors, along with intense competition, reflects the industry's enormous potential and development trends.

 

He called on all industry participants to focus on the product itself and user experience, rather than solely concentrate on price wars.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane’s 2026 update of its living review on electronic cigarettes for smoking cessation included 80 randomized controlled trials involving 29,861 adult smokers, with nine trials added in this update. The review retained its high-certainty conclusion that nicotine e-cigarettes increase smoking cessation rates compared with nicotine replacement therapy. In absolute terms, about 10 in 100 people using nicotine e-cigarettes may quit smoking for at least six months, compared with about 6 in 100 using NRT. The review found no clear difference in serious adverse event rates between the two groups, while longer-term safety and the relative effectiveness of newer device types remain less certain.
Sep.07
Arizona Turns to a 50% Retail Vape Tax as Tobacco Tax Revenue Falls 47% From 2008
Arizona Turns to a 50% Retail Vape Tax as Tobacco Tax Revenue Falls 47% From 2008
Arizona's First Things First is pushing for an excise tax equal to 50% of the retail price of vaping products, estimating that the measure could generate about $100 million annually. The agency says its tobacco-tax revenue has fallen 47% from 2008 levels. Arizona has attempted to broaden its nicotine tax base in each of the past two years: a 2025 bill proposed a 50% wholesale-price tax, while a 2026 measure shifted to a 50% retail-price tax covering alternative nicotine products and vapor products. Separately, the state enacted HB 4001 this year to establish a new licensing and sales framework for alternative nicotine products.
Sep.21
On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
FDA’s Center for Tobacco Products detailed new PMTA review data and process changes at the 2026 FDLI conference. Pending PMTAs fell from about 450,000 at the start of 2025 to 135,000 by September 2026. CTP also discussed its 180-day review goal, current sPMTA pilot, alternate-supplier planning, more than 50,300 pending SE reports, and lessons from the nicotine pouch pilot already being applied to ENDS review.
Regulations
Oct.07
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
American Vapor Manufacturers (AVM) and Altria subsidiaries Helix Innovations and NJOY filed separate motions on October 7, 2026, seeking to intervene on the FDA's side in a lawsuit challenging its enforcement guidance for certain e-cigarette and nicotine pouch products with pending premarket tobacco product applications (PMTAs). Seven public health and tobacco-control organizations, including the Campaign for Tobacco-Free Kids, sued the agency in July to overturn the policy. AVM argues that vacating the guidance could disrupt orders, inventory, retail distribution and investments in regulatory submissions.
Regulations
Oct.09
Virginia Tobacco Retail Permit Takes Effect October 1, Covering Vapes as More Than 3,000 Businesses Apply in September
Virginia Tobacco Retail Permit Takes Effect October 1, Covering Vapes as More Than 3,000 Businesses Apply in September
Virginia's new retail tobacco permit system took effect October 1, requiring sellers of vapes, nicotine products and related devices and accessories to obtain a Retail Tobacco Permit for each business location. Virginia ABC said more than 3,000 businesses applied in September alone, creating a processing backlog. Qualifying applicants that filed before October 1 may temporarily operate under a Letter of Authorization. The new store-level permit also sits alongside Virginia's existing vape product directory, where sales of unlisted liquid nicotine or nicotine vapor products can trigger civil penalties starting at $5,000.
Regulations
Oct.03
FDA Authorizes JUUL2, Cites Adult Switching Amid Efforts to Speed PMTA Reviews
FDA Authorizes JUUL2, Cites Adult Switching Amid Efforts to Speed PMTA Reviews
The FDA authorized the JUUL2 device and tobacco- and menthol-flavored pods on Aug. 28, bringing the number of authorized e-cigarette products to 48. The agency highlighted complete switching among adult smokers, with six-week switching rates reaching 28.4%–49.3% for the menthol pod. The decision comes as FDA works to speed PMTA reviews, reduce application backlogs and expand authorized e-cigarette and nicotine-pouch products while maintaining enforcement priorities for unauthorized products.
Regulations
Aug.29